Effects of the T-type calcium channel blockade with oral mibefradil on the electrophysiologic properties of the human heart

Medical Science Monitor

Volumn 7, Issue 1, 2001, Pages 74-77

  Mádle, Alois ^a   Linhartová, Kateřina ^a   Koza, Jiří ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atrioventricular node; Calcium antagonist; Electrophysiology; Mibefradil; Sinus node; T channel calcium blocker

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; MIBEFRADIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART ELECTROPHYSIOLOGY; HEART RATE; HUMAN; MALE; SINUS NODE;

ADULT; AGED; AGED, 80 AND OVER; ATRIOVENTRICULAR NODE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; FEMALE; HEART; HUMANS; MALE; MIBEFRADIL; MIDDLE AGED; SINOATRIAL NODE; SYNCOPE;

EID: 0035142529     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Fundamental properties of calcium antagonists including classification and molecular action
2. How do calcium antagonists differ in clinical practice?
3. 2+ channel selectivity
4. Influence of heart rate on mortality among persons with hypertension: The Framingham Study
5. The classification of calcium antagonists
6. The acute affects of intravenously administered mibefradil, a new calcium antagonist, on the electrophysiologic characteristics of the human heart
7. Ro 40-5967: A new nondihydropyridine calcium antagonist
8. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonist
9. Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension